Strides Pharma Science Limited has informed the Exchange about Sale or disposal
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science Limited, through its wholly-owned subsidiary Strides Pharma International Limited, has sold its 100% stake in Strides CIS Limited, Cyprus to unrelated buyers Mr. Sarvesh Bhargava and Mrs. Ranjana Bhargava (50% each) for a nominal consideration of USD 100. The Cyprus entity was a dormant company with nil revenue from operations and negligible net worth as of March 31, 2025. The sale is part of the company's effort to right-size its group structure and eliminate dormant entities. The transaction was executed on June 16, 2025, with completion happening simultaneously, and it is not a related party transaction.
This is a non-material, housekeeping transaction — the divested entity had no operations or meaningful contribution to consolidated financials. Shareholders should not expect any impact on earnings or stock price; it simply streamlines the group's corporate structure.